[
    [
        {
            "time": "2021-Q3",
            "orginal_text": "药明康德将回购注销57044股限制性A股",
            "features": {
                "keywords": [
                    "回购",
                    "注销",
                    "限制性A股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "药明康德将回购注销57044股限制性A股",
            "scores": {
                "News_content": "药明康德将回购注销57044股限制性A股",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-Q3",
            "orginal_text": "药明康德：变更会计政策",
            "features": {
                "keywords": [
                    "会计政策",
                    "变更"
                ],
                "sentiment_score": 0.2,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "药明康德：变更会计政策",
            "scores": {
                "News_content": "药明康德：变更会计政策",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-Q3",
            "orginal_text": "药明康德将回购注销合计16.03万股限制性A股及注销约33.09万份股票期权",
            "features": {
                "keywords": [
                    "回购",
                    "注销",
                    "限制性A股",
                    "股票期权"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "药明康德将回购注销合计16.03万股限制性A股及注销约33.09万份股票期权",
            "scores": {
                "News_content": "药明康德将回购注销合计16.03万股限制性A股及注销约33.09万份股票期权",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-Q3",
            "orginal_text": "药明康德新推五大业务板块，2021年前三季度归母净利润35.62亿元，同比增长50.41%",
            "features": {
                "keywords": [
                    "五大业务板块",
                    "净利润",
                    "增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "药明康德新推五大业务板块，2021年前三季度归母净利润35.62亿元，同比增长50.41%",
            "scores": {
                "News_content": "药明康德新推五大业务板块，2021年前三季度归母净利润35.62亿元，同比增长50.41%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-Q3",
            "orginal_text": "药明康德前三年度营收净利双增 新增客户超过1300家",
            "features": {
                "keywords": [
                    "营收",
                    "净利",
                    "新增客户"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "药明康德前三年度营收净利双增 新增客户超过1300家",
            "scores": {
                "News_content": "药明康德前三年度营收净利双增 新增客户超过1300家",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-Q3",
            "orginal_text": "药明康德：第三季度净利同比增长36% 葛兰旗下中欧医疗新进前十大流通股东",
            "features": {
                "keywords": [
                    "净利",
                    "增长",
                    "葛兰",
                    "中欧医疗"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "药明康德：第三季度净利同比增长36% 葛兰旗下中欧医疗新进前十大流通股东",
            "scores": {
                "News_content": "药明康德：第三季度净利同比增长36% 葛兰旗下中欧医疗新进前十大流通股东",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-Q3",
            "orginal_text": "2021年公募基金三季报分析：重仓股持续减持消费 港股遭大幅减持 减持股份数量",
            "features": {
                "keywords": [
                    "公募基金",
                    "减持",
                    "消费",
                    "港股"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "2021年公募基金三季报分析：重仓股持续减持消费 港股遭大幅减持 减持股份数量",
            "scores": {
                "News_content": "2021年公募基金三季报分析：重仓股持续减持消费 港股遭大幅减持 减持股份数量",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-Q3",
            "orginal_text": "北向资金连续13个月加仓A股，隆基股份获大幅净买入超10亿",
            "features": {
                "keywords": [
                    "北向资金",
                    "加仓",
                    "隆基股份"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "北向资金连续13个月加仓A股，隆基股份获大幅净买入超10亿",
            "scores": {
                "News_content": "北向资金连续13个月加仓A股，隆基股份获大幅净买入超10亿",
                "Correlation": 2,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]